Occasionally bone scintigraphy with technetium-99 based compounds may allude to, or increase the likelihood of, a diagnosis of prostate cancer, particularly in the setting of an incidental high PSA result in an otherwise unsuspecting patient. This evidence concerns the gene KLK3 and prostate carcinoma.